Diagnosing GLC1A: Beyond Eye Pressure

Confirming a diagnosis of GLC1A (MYOC-associated glaucoma) is more like solving a puzzle than taking a single blood test. A genetic test can identify an at-risk carrier, but it does not diagnose active glaucoma by itself. Because this condition can appear earlier and act more aggressively than typical glaucoma, your care team uses a combination of structural and functional tests to get a complete picture of your eye health ^[1][2].

It is important to understand that intraocular pressure (IOP) is only one piece of the puzzle. While high pressure is common in GLC1A, the diagnosis actually depends on whether there is evidence of damage to the optic nerve ^[3][4].

The Core Diagnostic Tools

To diagnose glaucoma, doctors look for a specific pattern: an open drainage angle combined with structural or functional damage to the optic nerve ^[3].

• Tonometry (Eye Pressure): This measures the fluid pressure inside your eye. In GLC1A, pressures are often significantly higher than the population reference range (typically 10–21 mmHg) ^[5]. However, some people with MYOC mutations may have normal pressure during an office visit while still having glaucoma—a situation known as normal-tension glaucoma, where characteristic glaucomatous damage occurs despite consistently untreated pressures in the normal range ^[6][3]. Furthermore, 10–21 mmHg is only a reference range, not a pressure guaranteed to be safe for every optic nerve.
• Gonioscopy (Angle Exam): This is a vital test where the doctor uses a special mirrored lens to look at the eye’s drainage angle ^[7]. It confirms the angle is “open” (meaning fluid can reach the drain) and helps rule out other conditions that can mimic GLC1A ^[8].
• OCT (Structural Scans): Optical Coherence Tomography uses light-based interferometric imaging to act like a high-resolution map for the eye. It measures the thickness of the Retinal Nerve Fiber Layer (RNFL) and the macular ganglion cell-inner plexiform layer (GCIPL) ^[1][9]. Thinning in these layers can be the first sign of glaucoma, often appearing before you notice any vision changes ^[10]. OCT interpretation requires your doctor to account for artifacts, near-sightedness (myopia), and individual disc anatomy.
• Visual Field Testing (Functional Exam): This test (automated perimetry) measures your peripheral vision. It tells the doctor if the structural thinning seen on the OCT is affecting how you actually see ^[1][11].

Ruling Out “Look-Alikes”

Because GLC1A often affects younger patients, doctors must ensure the high pressure isn’t caused by other rare or secondary conditions. Gonioscopy is the primary tool for this differentiation ^[7]:

• Axenfeld-Rieger Syndrome: This is a developmental condition where the eye’s drainage structures didn’t form perfectly. A doctor may see an anteriorly displaced “Schwalbe’s line” or iris attachments in the angle that aren’t present in pure GLC1A ^[12][13].
• Pigment Dispersion Syndrome: In this condition, pigment rubs off the back of the iris and clogs the drain. During gonioscopy, the doctor would see heavy, dark pigmentation in the drainage meshwork ^[14].
• Secondary Glaucomas: Other causes like past eye trauma (angle recession), inflammation (uveitis), or steroid use can also raise pressure and must be ruled out through a thorough history and exam ^[15][13].

Why “Normal” Tests Can Be Confusing

You might have high pressure but “normal” OCT and Visual Field results. In this case, you may be a glaucoma suspect or have ocular hypertension. This means your pressure is elevated, but it hasn’t caused permanent damage yet ^[10].

Conversely, some patients have preperimetric glaucoma, where the OCT shows thinning but the Visual Field is still perfect ^[10]. This is why using both tests is essential: the OCT is better at catching early disease, while the Visual Field is better at tracking progression in more advanced stages where OCT measurements may reach a “floor” ^[9][16].

By combining these tests and tracking the trend over time, your doctor can determine exactly where you are on the spectrum of GLC1A and tailor your treatment to prevent future vision loss ^[9].